CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 112759-113138
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T687","span":{"begin":0,"end":379},"obj":"Sentence"},{"id":"T81930","span":{"begin":0,"end":379},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The studied enrolled 3174 healthy children between the age of 12 and \u003c36 months whose parent or legal guardian gave written consent over 5 Table 2 , the efficacy of the vaccine against culture-confirmed illness was estimated to be 74.3% (95% CI 64.1-81.8) overall and the point estimates of efficacy against H1, H3 and B influenza infection were 82.3, 88.8, and 50, respectively."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T92","span":{"begin":0,"end":379},"obj":"Sentence"}],"text":"The studied enrolled 3174 healthy children between the age of 12 and \u003c36 months whose parent or legal guardian gave written consent over 5 Table 2 , the efficacy of the vaccine against culture-confirmed illness was estimated to be 74.3% (95% CI 64.1-81.8) overall and the point estimates of efficacy against H1, H3 and B influenza infection were 82.3, 88.8, and 50, respectively."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T631","span":{"begin":211,"end":214},"obj":"Disease"},{"id":"T632","span":{"begin":321,"end":340},"obj":"Disease"},{"id":"T633","span":{"begin":331,"end":340},"obj":"Disease"}],"attributes":[{"id":"A631","pred":"mondo_id","subj":"T631","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A632","pred":"mondo_id","subj":"T632","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A633","pred":"mondo_id","subj":"T633","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"The studied enrolled 3174 healthy children between the age of 12 and \u003c36 months whose parent or legal guardian gave written consent over 5 Table 2 , the efficacy of the vaccine against culture-confirmed illness was estimated to be 74.3% (95% CI 64.1-81.8) overall and the point estimates of efficacy against H1, H3 and B influenza infection were 82.3, 88.8, and 50, respectively."}